Commonwealth Equity Services’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$124K Buy
13,171
+3,085
+31% +$29.5K ﹤0.01% 4224
2026
Q1
$92.1K Hold
10,086
﹤0.01% 4147
2025
Q4
$75K Hold
10,086
﹤0.01% 4140
2025
Q3
$67K Sell
10,086
-161
-2% -$1.12K ﹤0.01% 4132
2025
Q2
$68K Sell
10,247
-18,564
-64% -$132K ﹤0.01% 4124
2025
Q1
$264K Buy
28,811
+1,324
+5% +$13.2K ﹤0.01% 3608
2024
Q4
$289K Buy
27,487
+17,405
+173% +$206K ﹤0.01% 3433
2024
Q3
$120K Hold
10,082
﹤0.01% 3836
2024
Q2
$58K Hold
10,082
﹤0.01% 3877
2024
Q1
$52K Buy
+10,082
New +$49.3K ﹤0.01% 3884

Other funds holding BVS

Commonwealth Equity Services's BVS Position: Q2 2026 in Review

Commonwealth Equity Services increased its Bioventus (BVS) stake by 31% in Q2 2026, buying an estimated $29.5K and bringing the position to 13,171 shares worth $124K. The position accounts for ﹤0.01% of the portfolio, ranked #4224.

Commonwealth Equity Services first reported a position in BVS in Q1 2024 and has held it in 10 quarters since. The position peaked at $289K in Q4 2024. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Commonwealth Equity Services held 13,171 shares of Bioventus worth $124K as of Q2 2026.
  • Commonwealth Equity Services bought 3,085 Bioventus shares in Q2 2026, an estimated $29.5K.
  • Bioventus made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #4224 holding.
  • Commonwealth Equity Services first reported a position in Bioventus in Q1 2024 and has held it in 10 quarters since.
  • Commonwealth Equity Services's Bioventus position peaked at $289K in Q4 2024.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.